Normosang Orphan Europe

Normosang Orphan Europe Uses, Dosage, Side Effects, Food Interaction and all others data.

Normosang Orphan Europe (trade name Panhematin) is an iron-containing porphyrin. More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.

Table Of contents

• Normosang Orphan Europe
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Normosang Orphan Europe
Availability	Prescription only
Generic	Hemin
Hemin Other Names	chloro(protoporphyrinato)iron(III), Hämin, Hemina, hémine, protohemin
Related Drugs	chlorpromazine, Thorazine, Givlaari, givosiran, Panhematin
Type
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country	Taiwan
Last Updated:	September 19, 2023 at 7:00 am

Uses

Normosang Orphan Europe is an iron-containing porphyrin injection used for the relief of recurrent attacks of acute intermittent porphyria (AIP) associated with the menstrual cycle when carbohydrate therapy is not effective.

Used in the management of porphyria attacks, particularly in acute intermittent porphyria.

Normosang Orphan Europe is also used to associated treatment for these conditions: Coproporphyria, Hereditary, Porphyrias, Acute, Variegate Porphyria

Food Interaction

No interactions found.

Normosang Orphan Europe Drug Interaction

Moderate: clopidogrel, clopidogrelUnknown: buspirone, buspirone, docusate, docusate, metoprolol, metoprolol, mirtazapine, mirtazapine, acetaminophen, acetaminophen, albuterol, albuterol, sertraline, sertraline

Normosang Orphan Europe Disease Interaction

Moderate: coagulation defects

Innovators Monograph

You find simplified version here Normosang Orphan Europe